These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2859788

  • 1. Exercise training during chronic beta blockade in cardiovascular disease.
    Fletcher GF.
    Am J Cardiol; 1985 Apr 26; 55(10):110D-113D. PubMed ID: 2859788
    [Abstract] [Full Text] [Related]

  • 2. Comparative review of beta-blocking agents.
    Jackson EA, Sullman SA.
    Conn Med; 1984 Apr 26; 48(4):213-5. PubMed ID: 6143648
    [No Abstract] [Full Text] [Related]

  • 3. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
    Burmeister WE, Reynolds RD, Lee RJ.
    Eur J Pharmacol; 1981 Oct 15; 75(1):7-10. PubMed ID: 6119212
    [Abstract] [Full Text] [Related]

  • 4. Managing angina with beta blockers.
    Segal BL, Kotler MN, Iskandrian AS.
    Geriatrics; 1982 Oct 15; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG, Hampton JR.
    Br J Clin Pharmacol; 1982 Jun 15; 13(6):841-6. PubMed ID: 6124268
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS, Crijns HJ, Brouwer J, van den Berg MP, Man in't Veld AJ, Mulder G, Lie KI.
    Circulation; 1995 Dec 15; 92(12):3415-23. PubMed ID: 8521562
    [Abstract] [Full Text] [Related]

  • 7. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ, Low RI, Paumer L, Amsterdam EA, Mason DT.
    Am J Cardiol; 1983 Jan 01; 51(1):13-8. PubMed ID: 6129794
    [Abstract] [Full Text] [Related]

  • 8. Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
    Wolfel EE, Hiatt WR, Brammell HL, Carry MR, Ringel SP, Travis V, Horwitz LD.
    Circulation; 1986 Oct 01; 74(4):664-74. PubMed ID: 2875812
    [Abstract] [Full Text] [Related]

  • 9. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB, Lacy CR, Krieger SD, Cosgrove NM.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [Abstract] [Full Text] [Related]

  • 10. [Beta-blockers and migraine].
    Massiou H, Bousser MG.
    Pathol Biol (Paris); 1992 Apr 01; 40(4):373-80. PubMed ID: 1353872
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
    Vik-Mo H, Maroko PR, Ribeiro LG.
    J Am Coll Cardiol; 1984 Oct 01; 4(4):735-41. PubMed ID: 6481013
    [Abstract] [Full Text] [Related]

  • 12. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL, Vukovich RA, Dennick LG, Groel JT, Willard DA.
    Clin Pharmacol Ther; 1980 Jan 01; 27(1):57-63. PubMed ID: 6101312
    [Abstract] [Full Text] [Related]

  • 13. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P.
    Eur Heart J; 1983 Jul 01; 4 Suppl D():1-12. PubMed ID: 6137366
    [Abstract] [Full Text] [Related]

  • 14. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R, Morganroth J, Freitag JA, Ronan JA, Lindgren KM, Donohue DJ, Larca LJ, Chadda KD, Olukotun AY.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [Abstract] [Full Text] [Related]

  • 15. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA, Crawford MH, O'Rourke RA.
    Chest; 1984 Aug 01; 86(2):189-93. PubMed ID: 6146499
    [Abstract] [Full Text] [Related]

  • 16. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH, Furberg CD, Friedewald WT.
    Curr Probl Cardiol; 1984 Jun 01; 9(3):1-50. PubMed ID: 6146495
    [No Abstract] [Full Text] [Related]

  • 17. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA, Foley JE, Brown B, Willard DA, Buckley M, O'Kelly D, Fitzgerald D, Tormey W, Darragh A.
    Br J Clin Pharmacol; 1979 Jun 01; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [Abstract] [Full Text] [Related]

  • 18. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE, Feldman RL, Hill JA, Pepine CJ.
    Am J Cardiol; 1987 Aug 01; 60(4):244-8. PubMed ID: 2887101
    [Abstract] [Full Text] [Related]

  • 19. Lipophilic versus hydrophilic beta(1) blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction.
    Kardos A, Long V, Bryant J, Singh J, Sleight P, Casadei B.
    Heart; 1998 Feb 01; 79(2):153-60. PubMed ID: 9538308
    [Abstract] [Full Text] [Related]

  • 20. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J, Frishman WH.
    N Engl J Med; 1981 Aug 27; 305(9):500-6. PubMed ID: 6114433
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.